#Kodiak Sciences
-

Kodiak Sciences Soars 160% After DAYBREAK Phase 3 Wet AMD Win
Kodiak Sciences shares surged after its DAYBREAK Phase 3 trial met primary endpoints for two retinal drug candidates. The result…

Kodiak Sciences shares surged after its DAYBREAK Phase 3 trial met primary endpoints for two retinal drug candidates. The result…